These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22839590)

  • 21. Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.
    Paterna S; Parrinello G; Di Pasquale P; Torres D; La Rocca G; Antona R; Vernuccio L; Fornaciari E; Tarantino A; Piccione E; Fasullo S; Licata G
    Adv Ther; 2007; 24(6):1260-70. PubMed ID: 18165208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
    Schnellbacher K; Bestehorn HP; Roskamm H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacologic importance of the combination atenolol/nifedipine in hypertensive patients].
    Carré A
    Drugs; 1998; 56 Suppl 2():23-30. PubMed ID: 9813739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of myocardial ischemia with reference to blood pressure values].
    Schneeweiss A; Wiegand V
    Cardiology; 1993; 82 Suppl 2():58-65. PubMed ID: 8100187
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hypertensive diabetic patients. Plus points for selective beta 1-blockade].
    MMW Fortschr Med; 2001 Jun; 143(23):43-4. PubMed ID: 11460423
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
    Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
    Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A comparative study of the membrane-protector efficacy of anaprilin and korinfar in hypertension patients].
    Gapon LI; Kremneva LV; Abaturova OV
    Lik Sprava; 1996; (10-12):69-71. PubMed ID: 9138819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug of the month. Maxsoten].
    Kulbertus H
    Rev Med Liege; 1996 May; 51(5):382-4. PubMed ID: 8992562
    [No Abstract]   [Full Text] [Related]  

  • 29. [New central agents in the treatment of arterial hypertension].
    Robles NR
    An Med Interna; 1999 Oct; 16(10):495-7. PubMed ID: 10603665
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical and metabolic effects of cardioselective beta-adrenoblockers nebivolol and metoprolol in patients with hypertension and ischemic heart disease associated with type 2 diabetes].
    Makolkin VI; Akhmedova OO; Buval'tsev VI; Gavrilov IuV; Petriĭ VV
    Kardiologiia; 2003; 43(2):40-3. PubMed ID: 12891271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta blockers for hypertension. No negative influence on insulin resistance].
    MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
    [No Abstract]   [Full Text] [Related]  

  • 32. β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
    Pathak A; Mrabeti S
    Vasc Health Risk Manag; 2021; 17():337-348. PubMed ID: 34135591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness.
    Sabidó M; Hohenberger T; Grassi G
    Pharmacol Res; 2018 Apr; 130():191-197. PubMed ID: 29366925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Level of hormones of pituitary-gonadal axis, penile blood flow and sexual function in men with arterial hypertension during monotherapy with bisoprolol and nebivolol].
    Nurmamedova GS; Gumbatov NB; Mustafaev II
    Kardiologiia; 2007; 47(6):50-3. PubMed ID: 18260876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction].
    Sárosi I; Debreceni G; Mühl D; Kónyi A; Bogár L; Tekeres M; Tóth K; Habon T; Czopf L; Zámbó K; Schmidt E
    Orv Hetil; 1997 Aug; 138(31):1939-45. PubMed ID: 9280886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium antagonists in the treatment of arterial hypertension].
    Kuznetsov VN
    Klin Med (Mosk); 1985 Nov; 63(11):9-15. PubMed ID: 2868150
    [No Abstract]   [Full Text] [Related]  

  • 38. Bisoprolol vs. chlorthalidone: a randomized, double-blind, comparative study in arterial hypertension.
    Bueno J; Amiguet JA; Carasusan J; Cebollada J; Carretero J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S189-92. PubMed ID: 11527126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].
    Wang B; Song WH; Liu GZ;
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):503-5. PubMed ID: 16080839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.